Infliximab biosimilar

BIOLOGICAL2 trials

Sponsors

TcLand Expression S.A., Hanyang University Seoul Hospital

Conditions

Ankylosing SpondylitisAxial SpondyloarthritisRheumatoId Arthritis

Phase 4

REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)

Hanyang University Seoul HospitalAnkylosing Spondylitis, Axial Spondyloarthritis

Start: 2022-01-15End: 2024-10-31Target: 448Updated: 2021-12-20

Unknown Phase

RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis

TerminatedNCT03016260

TcLand Expression S.A.RheumatoId Arthritis

Start: 2016-12-31End: 2019-12-20Updated: 2019-12-24